MindWalk Holdings Corp. (HYFT)
NASDAQ: HYFT · Real-Time Price · USD
2.000
-0.070 (-3.38%)
At close: Dec 5, 2025, 4:00 PM EST
2.040
+0.040 (2.00%)
After-hours: Dec 5, 2025, 7:48 PM EST

Company Description

MindWalk Holdings Corp. operates as a bio-native AI company.

It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics.

The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities.

The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025.

The company was incorporated in 1983 and is headquartered in Austin, Texas.

MindWalk Holdings Corp.
MindWalk Holdings logo
Country United States
Founded 1983
IPO Date Jan 3, 2017
Industry Biotechnology
Sector Healthcare
Employees 102
CEO Jennifer Bath

Contact Details

Address:
Industrious 823 Congress Ave, Suite 300
Austin, Texas 78701
United States
Phone 800 620 4187
Website mindwalkai.com

Stock Details

Ticker Symbol HYFT
Exchange NASDAQ
Fiscal Year May - April
Reporting Currency CAD
CIK Code 0001715925
CUSIP Number 45257F200
ISIN Number CA6026871054
SIC Code 2834

Key Executives

Name Position
Dr. Jennifer Lynne Bath Ph.D. Chief Executive Officer, President and Non-Independent Director
Kari Graber Vice President of Commercial Services
Dr. Shuji Sato Vice President of Innovative Solutions
Richard Scott Areglado Chief Financial Officer
Dirk Van Hyfte M.D., Ph.D. Chief Technology Officer
Frederic Chabot Head of Corporate Development
Ingrid Brands M.D., Ph.D. Chief Innovation and Strategy Officer
Dr. Thomas Lynch Ph.D. Chief Business Officer
Lori Anderson Vice President of Brand Marketing and Creative

Latest SEC Filings

Date Type Title
Nov 13, 2025 6-K Report of foreign issuer
Nov 7, 2025 6-K Report of foreign issuer
Nov 7, 2025 424B5 Filing
Nov 6, 2025 6-K Report of foreign issuer
Oct 21, 2025 6-K Report of foreign issuer
Oct 21, 2025 6-K Report of foreign issuer
Oct 20, 2025 S-8 Securities to be offered to employees in employee benefit plans
Oct 15, 2025 6-K Report of foreign issuer
Oct 14, 2025 6-K Report of foreign issuer
Oct 9, 2025 6-K Report of foreign issuer